STOCKHOLM, Aug. 5, 2024 /PRNewswire/ -- Calliditas's interim report for the second quarter, April - June 2024 will be published in Swedish and English on Tuesday 13 August 2024 at 07.00 a.m. CET.
A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.
The presentation will be given in English.
Link to the webcast:
https://ir.financialhearings.com/calliditas-therapeutics-q2-report-2024 [https://c212.net/c/link/?t=0&l=en&o=4225907-1&h=1332906195&u=https%3A%2F%2Fir.financialhearings.com%2Fcalliditas-therapeutics-q2-report-2024&a=https%3A%2F%2Fir.financialhearings.com%2Fcalliditas-therapeutics-q2-report-2024]
To participate via conference call please register via this link:
https://conference.financialhearings.com/teleconference/?id=50049712 [https://c212.net/c/link/?t=0&l=en&o=4225907-1&h=1315427844&u=https%3A%2F%2Fconference.financialhearings.com%2Fteleconference%2F%3Fid%3D50049712&a=https%3A%2F%2Fconference.financialhearings.com%2Fteleconference%2F%3Fid%3D50049712]
After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.
For further information, please contact:
Asa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com [mailto:asa.hillsten@calliditas.com]
The information was sent for publication, through the agency of the contact persons set out above, on August 5, 2024 at 7:00 a.m. CET.
This information was brought to you by Cision http://news.cision.com [https://c212.net/c/link/?t=0&l=en&o=4225907-1&h=2784167002&u=http%3A%2F%2Fnews.cision.com%2F&a=http%3A%2F%2Fnews.cision.com]
https://news.cision.com/calliditas-therapeutics/r/invitation-to-the-presentation-of-calliditas-s-interim-report-january---june-2024,c4019260 [https://c212.net/c/link/?t=0&l=en&o=4225907-1&h=2989206269&u=https%3A%2F%2Fnews.cision.com%2Fcalliditas-therapeutics%2Fr%2Finvitation-to-the-presentation-of-calliditas-s-interim-report-january---june-2024%2Cc4019260&a=https%3A%2F%2Fnews.cision.com%2Fcalliditas-therapeutics%2Fr%2Finvitation-to-the-presentation-of-calliditas-s-interim-report-january---june-2024%2Cc4019260]
The following files are available for download:
https://mb.cision.com/Main/16574/4019260/2928380.pdf Invitation to the presentation of Calliditas_Q2 2024 ENG
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--june-2024-302214090.html [https://www.prnewswire.co.uk/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--june-2024-302214090.html]
Calliditas Therapeutics